S&P 500   4,282.37
DOW   33,762.76
QQQ   354.65
MarketBeat Week in Review – 5/29 - 6/2
15 A.I. Trading Opportunities a Day (Ad)
Biden signs debt ceiling bill that pulls US back from brink of unprecedented default
Russia bans 'unfriendly' countries' journalists from showpiece economic gathering
15 A.I. Trading Opportunities a Day (Ad)
Slow start to New York's legal pot market leaves farmers holding the bag
Oil tanker breaks down in Egypt's Suez Canal, disrupting traffic in the global waterway
15 A.I. Trading Opportunities a Day (Ad)
With oil prices slumping, OPEC+ producers weigh more production cuts
Las Vegas ballpark pitch revives debate over public funding for sports stadiums
S&P 500   4,282.37
DOW   33,762.76
QQQ   354.65
MarketBeat Week in Review – 5/29 - 6/2
15 A.I. Trading Opportunities a Day (Ad)
Biden signs debt ceiling bill that pulls US back from brink of unprecedented default
Russia bans 'unfriendly' countries' journalists from showpiece economic gathering
15 A.I. Trading Opportunities a Day (Ad)
Slow start to New York's legal pot market leaves farmers holding the bag
Oil tanker breaks down in Egypt's Suez Canal, disrupting traffic in the global waterway
15 A.I. Trading Opportunities a Day (Ad)
With oil prices slumping, OPEC+ producers weigh more production cuts
Las Vegas ballpark pitch revives debate over public funding for sports stadiums
S&P 500   4,282.37
DOW   33,762.76
QQQ   354.65
MarketBeat Week in Review – 5/29 - 6/2
15 A.I. Trading Opportunities a Day (Ad)
Biden signs debt ceiling bill that pulls US back from brink of unprecedented default
Russia bans 'unfriendly' countries' journalists from showpiece economic gathering
15 A.I. Trading Opportunities a Day (Ad)
Slow start to New York's legal pot market leaves farmers holding the bag
Oil tanker breaks down in Egypt's Suez Canal, disrupting traffic in the global waterway
15 A.I. Trading Opportunities a Day (Ad)
With oil prices slumping, OPEC+ producers weigh more production cuts
Las Vegas ballpark pitch revives debate over public funding for sports stadiums
S&P 500   4,282.37
DOW   33,762.76
QQQ   354.65
MarketBeat Week in Review – 5/29 - 6/2
15 A.I. Trading Opportunities a Day (Ad)
Biden signs debt ceiling bill that pulls US back from brink of unprecedented default
Russia bans 'unfriendly' countries' journalists from showpiece economic gathering
15 A.I. Trading Opportunities a Day (Ad)
Slow start to New York's legal pot market leaves farmers holding the bag
Oil tanker breaks down in Egypt's Suez Canal, disrupting traffic in the global waterway
15 A.I. Trading Opportunities a Day (Ad)
With oil prices slumping, OPEC+ producers weigh more production cuts
Las Vegas ballpark pitch revives debate over public funding for sports stadiums
NASDAQ:CDNA

CareDx (CDNA) Stock Forecast, Price & News

$8.13
+0.12 (+1.50%)
(As of 06/2/2023 ET)
Compare
Today's Range
$7.89
$8.28
50-Day Range
$7.61
$9.46
52-Week Range
$6.22
$27.35
Volume
519,039 shs
Average Volume
709,599 shs
Market Capitalization
$437.34 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$16.00

CareDx MarketRank™ Forecast

Analyst Rating
Hold
2.20 Rating Score
Upside/​Downside
96.8% Upside
$16.00 Price Target
Short Interest
Bearish
11.97% of Float Sold Short
Dividend Strength
N/A
Sustainability
-0.66
Upright™ Environmental Score
News Sentiment
0.90mentions of CareDx in the last 14 days
Based on 5 Articles This Week
Insider Trading
Selling Shares
$71,030 Sold Last Quarter
Proj. Earnings Growth
Growing
From ($1.73) to ($1.41) Per Share

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

1.88 out of 5 stars

Medical Sector

654th out of 983 stocks

Medical Laboratories Industry

17th out of 22 stocks


CDNA stock logo

About CareDx (NASDAQ:CDNA) Stock

CareDx, Inc. operates as a transplant diagnostics company, which discovers, develops and commercializes diagnostic solutions. Its products include AlloMap, AlloSure and Laboratory products. The company was founded on December 21, 1998 and is headquartered in Brisbane, CA.

Receive CDNA Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for CareDx and its competitors with MarketBeat's FREE daily newsletter.

CDNA Stock News Headlines

66,000% upside on tiny biotech?
The Wall Street Journal reports that this medical breakthrough is "Transforming Medicine." One analyst calculated that it could be worth $1 Trillion, making the upside potential of this small-cap 66,000% above today's price.
Should You Exit CareDx (CDNA)?
CareDx (NASDAQ:CDNA) Lowered to "Neutral" at BTIG Research
8-K: CareDx, Inc.
⚡ 2,467% Return on Israeli Laser Company?
This advanced laser system is active in 80 countries around the world. And at the center of this massive market is a small firm in Israel. Our research shows that anyone who gets in today could see a return of 2,467%. But that's only if the company doesn't get taken over for a fast 300% gain first.
BTIG Downgrades Caredx (CDNA)
CareDx (CDNA) Receives a Hold from H.C. Wainwright
A Preview Of CareDx's Earnings
CareDx Reports First Quarter 2023 Results
CareDx (NASDAQ:CDNA) Stock Price Up 8.9%
See More Headlines

CDNA Price History

CDNA Company Calendar

Last Earnings
10/28/2021
Today
6/03/2023
Next Earnings (Estimated)
8/03/2023
Fiscal Year End
12/31/2023

Industry, Sector and Symbol

Industry
Medical laboratories
Sub-Industry
N/A
Sector
Medical
Current Symbol
NASDAQ:CDNA
Employees
633
Year Founded
N/A

Price Target and Rating

Average Stock Price Forecast
$16.00
High Stock Price Forecast
$25.00
Low Stock Price Forecast
$9.00
Forecasted Upside/Downside
+96.8%
Consensus Rating
Hold
Rating Score (0-4)
2.20
Research Coverage
5 Analysts

Profitability

Net Income
$-76,610,000.00
Pretax Margin
-25.09%

Debt

Sales & Book Value

Annual Sales
$319.64 million
Book Value
$7.81 per share

Miscellaneous

Free Float
51,319,000
Market Cap
$437.34 million
Optionable
Optionable
Beta
1.01

Key Executives

  • Reginald SeetoReginald Seeto
    President, Chief Executive Officer & Director
  • Marica Grskovic
    Chief Operations Officer
  • Abhishek Jain
    Chief Financial & Accounting Officer
  • Srini Srinivas
    SVP-Medical Affairs & Clinical Operations
  • Ashish Kothari
    Vice President-Medical Affairs













CDNA Stock - Frequently Asked Questions

Should I buy or sell CareDx stock right now?

5 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for CareDx in the last twelve months. There are currently 4 hold ratings and 1 buy rating for the stock. The consensus among Wall Street equities research analysts is that investors should "hold" CDNA shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in CDNA, but not buy additional shares or sell existing shares.
View CDNA analyst ratings
or view top-rated stocks.

What is CareDx's stock price forecast for 2023?

5 brokerages have issued 12 month target prices for CareDx's shares. Their CDNA share price forecasts range from $9.00 to $25.00. On average, they predict the company's stock price to reach $16.00 in the next year. This suggests a possible upside of 96.8% from the stock's current price.
View analysts price targets for CDNA
or view top-rated stocks among Wall Street analysts.

How have CDNA shares performed in 2023?

CareDx's stock was trading at $11.41 at the beginning of 2023. Since then, CDNA stock has decreased by 28.7% and is now trading at $8.13.
View the best growth stocks for 2023 here
.

Are investors shorting CareDx?

CareDx saw a increase in short interest in the month of May. As of May 15th, there was short interest totaling 6,200,000 shares, an increase of 19.2% from the April 30th total of 5,200,000 shares. Based on an average trading volume of 1,380,000 shares, the short-interest ratio is presently 4.5 days. Approximately 12.0% of the shares of the stock are short sold.
View CareDx's Short Interest
.

When is CareDx's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Thursday, August 3rd 2023.
View our CDNA earnings forecast
.

How were CareDx's earnings last quarter?

CareDx, Inc (NASDAQ:CDNA) announced its earnings results on Thursday, October, 28th. The company reported $0.07 earnings per share for the quarter, topping the consensus estimate of ($0.14) by $0.21. The business earned $75.60 million during the quarter, compared to the consensus estimate of $74.11 million. CareDx had a negative trailing twelve-month return on equity of 18.65% and a negative net margin of 25.25%. The business's revenue for the quarter was up 41.6% compared to the same quarter last year. During the same period last year, the business posted ($0.06) earnings per share.

What other stocks do shareholders of CareDx own?

Based on aggregate information from My MarketBeat watchlists, some companies that other CareDx investors own include Block (SQ), Roku (ROKU), Exact Sciences (EXAS), NVIDIA (NVDA), Advanced Micro Devices (AMD), Tesla (TSLA), Enphase Energy (ENPH), Johnson & Johnson (JNJ), Activision Blizzard (ATVI) and Alibaba Group (BABA).

What is CareDx's stock symbol?

CareDx trades on the NASDAQ under the ticker symbol "CDNA."

Who are CareDx's major shareholders?

CareDx's stock is owned by a variety of retail and institutional investors. Top institutional shareholders include ARK Investment Management LLC (12.67%), State Street Corp (9.07%), BlackRock Inc. (8.13%), Armistice Capital LLC (5.83%), Sumitomo Mitsui Trust Holdings Inc. (5.12%) and Nikko Asset Management Americas Inc. (5.12%). Insiders that own company stock include Ankur Dhingra, George Bickerstaff, Grace Colon, Michael Brian Bell, Michael Goldberg, Paul Adler, Peter Maag, Ralph Snyderman, Reginald Seeto, Sasha King, Thomas A Thomas and William A Hagstrom.
View institutional ownership trends
.

How do I buy shares of CareDx?

Shares of CDNA stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is CareDx's stock price today?

One share of CDNA stock can currently be purchased for approximately $8.13.

How much money does CareDx make?

CareDx (NASDAQ:CDNA) has a market capitalization of $437.34 million and generates $319.64 million in revenue each year. The company earns $-76,610,000.00 in net income (profit) each year or ($1.51) on an earnings per share basis.

How many employees does CareDx have?

The company employs 633 workers across the globe.

How can I contact CareDx?

CareDx's mailing address is 1 TOWER PLACE 9TH FLOOR, SOUTH SAN FRANCISCO CA, 94080. The official website for the company is www.caredxinc.com. The company can be reached via phone at (415) 287-2300, via email at caroline.corner@westwicke.com, or via fax at 415-287-2450.

This page (NASDAQ:CDNA) was last updated on 6/4/2023 by MarketBeat.com Staff

My Account -